Aura Biosciences, Inc.
AURA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $32 | $41 | $122 | $149 |
| Short-Term Investments | $119 | $185 | $67 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $10 | $6 | $8 | $5 |
| Total Curr. Assets | $161 | $232 | $197 | $154 |
| Property Plant & Equip (Net) | $21 | $22 | $26 | $6 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $1 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $1 | $0 | $0 |
| Total NC Assets | $22 | $23 | $27 | $6 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $183 | $255 | $224 | $160 |
| Liabilities | – | – | – | – |
| Payables | $2 | $2 | $3 | $2 |
| Short-Term Debt | $3 | $3 | $3 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $9 | $8 | $5 | $4 |
| Total Curr. Liab. | $15 | $12 | $10 | $7 |
| LT Debt | $16 | $17 | $18 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $16 | $17 | $18 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $19 | $20 | $21 | $1 |
| Total Liabilities | $31 | $29 | $28 | $8 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$374 | -$287 | -$211 | -$152 |
| AOCI | $0 | $1 | -$0 | $0 |
| Other Equity | $526 | $513 | $407 | $304 |
| Total Equity | $152 | $226 | $196 | $152 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $183 | $255 | $224 | $160 |
| Net Debt | -$13 | -$22 | -$101 | -$148 |